Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Vitoria – page 6

109 clinical trials in Vitoria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Vitoria at a glance
109
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

109 trials in Vitoria

Open in trial search

Hepatitis alcoholic

Not yet recruiting

Study on the Effectiveness of N-Acetylcysteine and Methylprednisolone for Patients with Severe Acute Alcoholic Hepatitis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine
  • Sponsor:Asociacion Instituto De Investigacion Sanitaria Bioaraba

Urinary tract infection

Not yet recruiting

Study on the Safety and Effectiveness of Fosfomycin Calcium for Treating Uncomplicated Urinary Tract Infections in Adult Women

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin calcium
  • Sponsor:Asociacion Instituto De Investigacion Sanitaria Bioaraba

Hypophosphatasia

Not yet recruiting

Study of ALXN1850 for Children Aged 2 to 12 with Hypophosphatasia Who Have Not Previously Received Asfotase Alfa Treatment

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:ALXN1850
  • Sponsor:Alexion Pharmaceuticals Inc.

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Sjogren's syndrome

Not recruiting

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Sjogren's syndrome

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study of GLPG3667 for Adults with Active Systemic Lupus Erythematosus

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:GLPG3667 fumarate
  • Sponsor:Lakefront Biotherapeutics

Ovarian cancer

Not recruiting

Phase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:INCB123667
  • Sponsor:Incyte Corp.

Hip fracture

Not recruiting

Efficacy of Tranexamic Acid in Reducing Perioperative Blood Loss in Patients with Hip Fracture: A Randomized, Double-Blind Clinical Trial

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tranexamic Acid
  • Sponsor:Asociacion Instituto Biogipuzkoa

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

Psoriatic arthropathy

Not recruiting

Study on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Vitoria

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on breast cancer treatments, including studies of atezolizumab with chemotherapy and novel approaches for HER2-positive breast cancer. Additional research explores treatments for bladder cancer and pancreatic adenocarcinoma.

  • Triple-negative breast cancer therapy
  • Non-muscle invasive bladder cancer treatment
  • Metastatic cancer interventions

Researchers are evaluating both immunotherapy and targeted treatments to improve patient outcomes.

02 Autoimmune Disorders

Comprehensive studies examining treatments for Sjögren's Syndrome and systemic lupus erythematosus. Research includes evaluation of novel therapies like dazodalibep and efgartigimod for managing autoimmune conditions.

  • Primary Sjögren's Disease treatments
  • Lupus management strategies
  • Innovative biological therapies

Focus on long-term safety and efficacy of new therapeutic approaches.

03 Neurological Conditions

Studies investigating treatments for multiple sclerosis, narcolepsy, and idiopathic hypersomnia. Research includes evaluation of remibrutinib and novel sleep disorder therapies.

  • MS relapse reduction
  • Sleep disorder management
  • Neurological therapeutic advances

Emphasis on developing targeted treatments for better disease control.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.